Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

OBJECTIVE: To quantify randomness and cost when choosing health and medical research projects for funding. DESIGN: Retrospective analysis. SETTING: Grant review panels of the National Health and Medical Research Council of Australia. PARTICIPANTS: Panel members' scores for grant proposals submitted in 2009. MAIN OUTCOME MEASURES: The proportion of grant proposals that were always, sometimes, and never funded after accounting for random variability arising from differences in panel members' scores, and the cost effectiveness of different size assessment panels. RESULTS: 59% of 620 funded grants were sometimes not funded when random variability was taken into account. Only 9% (n = 255) of grant proposals were always funded, 61% (n = 1662) never funded, and 29% (n=788) sometimes funded. The extra cost per grant effectively funded from the most effective system was $A18,541 (£11,848; €13,482; $19,343). CONCLUSIONS: Allocating funding for scientific research in health and medicine is costly and somewhat random. There are many useful research questions to be addressed that could improve current processes.

Original publication

DOI

10.1136/bmj.d4797

Type

Journal article

Journal

BMJ

Publication Date

27/09/2011

Volume

343

Keywords

Australia, Costs and Cost Analysis, Financing, Organized, Research Support as Topic, Retrospective Studies